NLS Global report

Accumulus Synergy’s cloud-based data-sharing platform could accelerate access to vaccines and other health technologies by enabling multi-country regulatory submissions and expediting regulatory review and approval, potentially helping to end future emerging infectious disease outbreaks swiftly and more equitably.

Norwegian company AdjuTec’s novel antibiotic resistance breakers may help to facilitate reduced use of antibiotics – and the company is now ready to test its product in humans.

Lithuanian company Celltechna has opened the first and only gene therapy centre in the Baltic States in Vilnius, Lithuania.

It is the first case caused by clade I to be diagnosed outside the African continent, reports the Public Health Agency of Sweden. “In this case a person has been infected during a stay in the part of Africa where there is a major outbreak of mpox clade I. The person in Sweden who has […]

Getting back to work after a long and relaxing holiday can be quite hard, here is some advice to make things easier and make your return less stressful.

Botond Roska and José-Alain Sahel have been awarded the Wolf Prize in Medicine for their pioneering work on restoring vision to blind patients using optogenetic therapy. The Wolf Prize recognizes outstanding achievements in various fields including medicine. Botond Roska and José-Alain Sahel Roska, Director at the Institute of Molecular and Clinical Ophthalmology Basel (IOB) and […]